Results 1 to 8 of 8
Page 1 of 1
Retracted: outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen.Hui, CK; Cheung, WW; Leung, KW; Cheng, VCC; Tang, BSF; Li, IWS; Luk, JM; Lee, NP; Kwong, YL; Au, WY; Yuen, KY; Lau, GK; Liang, R200885
Regular virologic surveillance showed very frequent cytomegalovirus reactivation in patients treated with alemtuzumabCheung, WW; Tse, E; Leung, AYH; Yuen, KY; Kwong, YL2007148
Rituximab increases the risk of de novo hepatitis B infection in hepatitis B surface antigen negative patients undergoing cytotoxic chemotherapyHui, CK; Cheung, WW; Zhang, H; Au, WY; Yueng, YH; Leung, AYH; Leung, N; Luk, JMC; Lie, AKW; Kwong, YL; Liang, RHS; Lau, G2006169
Hepatitis B vaccination and preemptive treatment of hepatitis B virus in liver transplantationHui, CK; Cheung, WW; Chan, SC; Lo, CM; Lau, GK2006141
Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab.Cheung, WW; Hwang, GY; Tse, E; Kwong, YL200684
The role of cholecystectomy in reducing recurrent gallstone pancreatitisHui, CK; Lai, KC; Yuen, MF; Wong, WM; Chan, AOO; Ng, M; Chan, CK; Cheung, WW; Lam, SK; Lai, CL; Wong, BCY2004109
Outpatients undergoing therapeutic endoscopic retrograde cholangiopancreatography: Six-hour versus overnight observationHui, CK; Lai, KC; Wong, WM; Yuen, MF; Ng, M; Chan, CK; Hu, W; Cheung, WW; Lai, CL; Wong, BC2004120
Outcome of emergency ERCP for acute cholangitis in patients 90 years of age and olderHui, CK; Liu, CL; Lai, KC; Chan, SC; Hu, WHC; Wong, WM; Cheung, WW; Ng, M; Yuen, MF; Chan, AO; Lo, CM; Fan, ST; Wong, BCY2004134
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download